Younger (< 50 years) multiple myeloma (MM) patients (pts) treated with novel agents and autologous haematopoietic stem cell transplantation (auto-HCT) have longer overall survival than older pts (>= 50 years)

BONE MARROW TRANSPLANTATION(2013)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要